Safety and Risk/Benefit Analysis of Ibutilide for Acute Conversion of Atrial Fibrillation/Flutter
- 1 October 1996
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 78 (8) , 46-52
- https://doi.org/10.1016/s0002-9149(96)00566-8
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: A dose-response studyJournal of the American College of Cardiology, 1996
- Atrial Fibrillation Begets Atrial FibrillationCirculation, 1995
- Management of Atrial FibrillationNew England Journal of Medicine, 1992
- Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsades de pointesThe American Journal of Cardiology, 1992
- Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutterThe American Journal of Cardiology, 1991
- Cardioversion of atrial flutter by intravenous ibutilide, a new class III antiarrhythmic agentJournal of the American College of Cardiology, 1991
- Aggravation of arrhythmia by antiarrhythmic drugs—Incidence and predictorsThe American Journal of Cardiology, 1987
- Digoxin for Converting Recent-Onset Atrial Fibrillation to Sinus RhythmAnnals of Internal Medicine, 1987
- Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmiasAmerican Heart Journal, 1986
- Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide infusionAmerican Heart Journal, 1983